KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Research & Development (2018 - 2025)

Historic Research & Development for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $151.5 million.

  • Vir Biotechnology's Research & Development fell 2239.75% to $151.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.7 million, marking a year-over-year decrease of 700.5%. This contributed to the annual value of $506.5 million for FY2024, which is 1263.04% down from last year.
  • As of Q3 2025, Vir Biotechnology's Research & Development stood at $151.5 million, which was down 2239.75% from $97.5 million recorded in Q2 2025.
  • Vir Biotechnology's 5-year Research & Development high stood at $195.2 million for Q3 2024, and its period low was $86.1 million during Q2 2021.
  • Over the past 5 years, Vir Biotechnology's median Research & Development value was $115.1 million (recorded in 2022), while the average stood at $125.1 million.
  • Per our database at Business Quant, Vir Biotechnology's Research & Development soared by 10755.94% in 2021 and then plummeted by 3746.36% in 2024.
  • Vir Biotechnology's Research & Development (Quarter) stood at $128.3 million in 2021, then increased by 20.91% to $155.2 million in 2022, then fell by 29.78% to $109.0 million in 2023, then decreased by 2.65% to $106.1 million in 2024, then soared by 42.78% to $151.5 million in 2025.
  • Its last three reported values are $151.5 million in Q3 2025, $97.5 million for Q2 2025, and $118.6 million during Q1 2025.